Evotec, DE0005664809

Evotec Stock - Thursday’s technical picture and chart levels

Published on 06/18/2026 at 21:40 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Evotec stock lacked fresh corporate news on Thursday, leaving the focus on the fragile chart, key technical levels and how the biotech name trades around its 200-day moving average compared with recent lows.

Evotec, DE0005664809, Illustration mit AI erstellt.
Evotec, DE0005664809, Illustration mit AI erstellt.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 21:37 CET. Details in the imprint.

Evotec (DE0005664809) spent Thursday without fresh corporate headlines, so attention turned to the stock’s technical setup and recent trading range. The shares hovered in the mid-EUR 4 band on German platforms, according to current Tradegate and Xetra data.

Go deeper

All news and price data on Evotec stock

Further background, historical reports and intraday quotes on Evotec stock are available in the dedicated topic overview on ad-hoc-news.de.

What today’s trading shows

On Thursday, Evotec shares most recently changed hands around EUR 4.70 on German off-exchange platform Tradegate, with only modest intraday variation and no clear directional impulse from newsflow, according to a same-day ad-hoc news overview based on Tradegate data.

On Xetra, where Evotec is also listed under ticker EVT, MarketScreener quotes showed levels in a similar corridor, with the last price around EUR 4.73 and a daily move of less than 1% in either direction.

Key technical levels on Thursday

Against this backdrop, the technical picture remains fragile. The shares are trading not far above recent lows, while short-term resistance is seen close to current prices given repeated failures to sustain moves meaningfully above the mid-EUR 4 band in recent sessions.

Data compiled by MarketScreener indicate that Evotec stock currently trades below its 200-day moving average on Xetra, underlining a cautious medium-term trend even as day-to-day volatility has moderated in recent weeks.

How the company makes money

Evotec SE positions itself as a drug discovery and development partner for the pharmaceutical and biotech industry, generating revenue primarily from research collaborations, milestones and service fees across areas such as neurology, oncology and metabolic diseases.

Where the stock trades today

The shares of Evotec (DE0005664809) most recently traded on Xetra around EUR 4.73 as of 06/18/2026, 11:00 CET.

Key facts on Evotec stock

  • Company: Evotec SE
  • ISIN: DE0005664809
  • WKN: 566480
  • Ticker: EVT
  • Venue: Xetra
  • Price (as of 06/18/2026, 11:00 CET): 4.73 EUR
  • Market cap: 919,860,000 EUR (as of 06/18/2026)
  • Sector / Industry: Health Care / Pharmaceuticals - Specialty and Generic
  • Index membership: TecDAX, SDAX, HDAX, SDAX Kursindex
  • Next earnings date: not officially scheduled

More on Evotec stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0005664809 | EVOTEC | boerse | 69576353 | bgmi